| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1097-0142(19980615)82:12<2366::AID-CNCR10>3.3.CO;2-B |
| P698 | PubMed publication ID | 9635529 |
| P2093 | author name string | Buzdar AU | |
| Pham T | |||
| Hursting SD | |||
| Chang S | |||
| Parker SL | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | epidemiology | Q133805 |
| breast carcinoma | Q18555947 | ||
| inflammatory breast carcinoma | Q18557197 | ||
| P304 | page(s) | 2366-2372 | |
| P577 | publication date | 1998-06-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992. | |
| P478 | volume | 82 |
| Q36546465 | A comparison of cholesterol uptake and storage in inflammatory and noninflammatory breast cancer cells |
| Q30724470 | A comparison of criteria to identify inflammatory breast cancer cases from medical records and the Surveillance, Epidemiology and End Results data base, 2007-2009. |
| Q36187733 | An "elite hacker": breast tumors exploit the normal microenvironment program to instruct their progression and biological diversity |
| Q33636065 | Analysis of RhoC expression and lymphovascular emboli in inflammatory vs non-inflammatory breast cancers in Egyptian patients |
| Q35662191 | Association of inflammatory and noninflammatory breast cancer with socioeconomic characteristics in the Surveillance, Epidemiology, and End Results database, 2000-2007. |
| Q37619725 | Beta protein 1 homeoprotein induces cell growth and estrogen-independent tumorigenesis by binding to the estrogen receptor in breast cancer. |
| Q45150963 | Bilateral inflammatory metachronic ERBB2 (HER2/neu)-positive breast carcinoma: prolonged survival with combined chemotherapy and trastuzumab |
| Q37687382 | Biology and management of inflammatory breast cancer |
| Q37598890 | Breast cancer: beyond the cutting edge |
| Q28255036 | Breast metastases of gastric signet-ring cell carcinoma: a report of two cases and review of the literature |
| Q37885436 | Canine mammary tumours, an overview |
| Q43885631 | Case control study of prognostic markers and disease outcome in inflammatory carcinoma breast: a unique clinical experience |
| Q33760216 | Challenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast Cancer |
| Q36598732 | Characterizing inflammatory breast cancer among Arab Americans in the California, Detroit and New Jersey Surveillance, Epidemiology and End Results (SEER) registries (1988-2008). |
| Q36611240 | Concomitant intensive chemoradiotherapy induction in non-metastatic inflammatory breast cancer: long-term follow-up |
| Q37592080 | Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties |
| Q58701459 | Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Center |
| Q36614754 | Early onset of breast cancer in a group of British black women |
| Q33781315 | Epidemiology of inflammatory breast cancer (IBC). |
| Q35007782 | Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancer |
| Q46511043 | Expression of WISP3 and RhoC genes at mRNA and protein levels in inflammatory and noninflammatory breast cancer in Tunisian patients |
| Q24805938 | First description of feline inflammatory mammary carcinoma: clinicopathological and immunohistochemical characteristics of three cases |
| Q34589568 | Human cytomegalovirus infection enhances NF-κB/p65 signaling in inflammatory breast cancer patients |
| Q36031290 | Importance of hereditary and selected environmental risk factors in the etiology of inflammatory breast cancer: a case-comparison study |
| Q37627127 | Incidence of inflammatory breast cancer in women, 1992-2009, United States |
| Q34918360 | Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990-2008. |
| Q34918207 | Inflammatory breast cancer in north Africa: comparison of clinical and molecular epidemiologic characteristics of patients from Egypt, Tunisia, and Morocco |
| Q39962699 | Inflammatory breast cancer-comparing the effectivity of preoperative docetaxel-epirubicine protocol to conventional antracycline-containing chemotherapy to achieve clinical benefit and complete pathological response |
| Q27027856 | Inflammatory breast cancer: New factors contribute to disease etiology: A review |
| Q35939285 | Inflammatory breast cancer: is it really a separate entity? |
| Q55122090 | Influence of patient, physician, and hospital characteristics on the receipt of guideline-concordant care for inflammatory breast cancer. |
| Q22000757 | Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion |
| Q60931821 | Introduction of a New Staging System of Breast Cancer for Radiologists: An Emphasis on the Prognostic Stage |
| Q37355729 | Lapatinib: new opportunities for management of breast cancer |
| Q91641578 | Literature review of data-based models for identification of factors associated with racial disparities in breast cancer mortality |
| Q74267179 | Locally advanced breast cancer |
| Q41110592 | Lymph node status in inflammatory breast cancer. |
| Q38350939 | Management of locally advanced breast cancer-perspectives and future directions |
| Q33317058 | Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: prominent expression of P-cadherin |
| Q35572495 | Molecular epidemiologic features of inflammatory breast cancer: a comparison between Egyptian and US patients |
| Q37321807 | Molecular profiling including epidermal growth factor receptor and p21 expression in high-risk breast cancer patients as indicators of outcome |
| Q90428103 | Nomogram for predicting cancer specific survival in inflammatory breast carcinoma: a SEER population-based study |
| Q55665058 | Outcome of inflammatory breast cancer in Moroccan patients: clinical, molecular and pathological characteristics of 219 cases from the National Oncology Institute (INO). |
| Q61451208 | Pathologic Complete Response (pCR) and Survival of Women with Inflammatory Breast Cancer (IBC): An Analysis Based on Biologic Subtypes and Demographic Characteristics |
| Q36578574 | Photodynamic therapy as an effective therapeutic approach in MAME models of inflammatory breast cancer |
| Q35624765 | Prognostic significance of HER-2 status in women with inflammatory breast cancer |
| Q45067157 | Racial and Socioeconomic Disparities Are More Pronounced in Inflammatory Breast Cancer Than Other Breast Cancers |
| Q24817154 | Short- and long-term cause-specific survival of patients with inflammatory breast cancer |
| Q36356303 | Spontaneously-forming spheroids as an in vitro cancer cell model for anticancer drug screening |
| Q34363419 | Targeted treatment of advanced and metastaticbreast cancer with lapatinib. |
| Q33692229 | The anti-carcinogenic effects of dietary restriction: mechanisms and future directions |
| Q36461733 | The current understanding of the molecular determinants of inflammatory breast cancer metastasis |
| Q54263447 | Treatment adherence and outcome in women with inflammatory breast cancer: does race matter? |
| Q33751139 | Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute |
| Q24797853 | Update on inflammatory breast cancer |
| Q37210821 | What can we learn from the age- and race/ethnicity- specific rates of inflammatory breast carcinoma? |
| Q37307189 | What is inflammatory breast cancer? Revisiting the case definition |
| Q74334425 | [Alternating chemotherapy and hyperfractionated accelerated radiotherapy in non-metastatic inflammatory breast cancer] |
Search more.